JPRN-UMIN000007379
Recruiting
未知
Developement of minimaly invasive chemoradiotherapy with a method of sentinel lymph node for head and neck cancer - Minimaly invasive chemoradiotherapy with sentinel lymph node for head and neck cancer
Juntendo University school of medicine0 sites20 target enrollmentFebruary 25, 2012
Conditionshead and neck cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- head and neck cancer
- Sponsor
- Juntendo University school of medicine
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1,distant metastasis 2,previously treated patients 3,A history of radiation therapy for the neck 4,pregnancy or lactating women or women with suspected pregnancy 5,Patients judged by the investigator to be unfit to be enrolled into the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pilot study of definitive chemoradiotherapy using involved-field intensity-modulatd radiation therapy for patients with clinical stage IB-IIIC (non T4) esophageal carcinomaEsophageal neoplasmJPRN-UMIN000017668Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University12
Completed
Not Applicable
Targeted radiotherapy for chemotherapy resistant neuroblastoma with I-131 metaiodobenzylguanidine (MIBG)neuroblastomaJPRN-UMIN000002530Kanazawa University Hospital90
Completed
Phase 1
PhaseI/II trial of neoadjvant chemoradiotherapy with docetaxel,CDDP and 5-Fluorouracil followed by surgery in patients with advanced esophageal cancer.Esophageal CancerJPRN-UMIN000002137Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University40
Completed
Not Applicable
Preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer: single institutional pilot studyRectal cancerJPRN-UMIN000024549Kyoto university12
Completed
Phase 1
Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Canceradvanced or recurrence esophageal carcinomaJPRN-UMIN000003634Department of Surgery, Graduate School of Medicine, Osaka University18